The budget and upcoming reform of the NHS could be the start of new era for medical technology – but to harness its potential we need to get spread and adoption right, says Barbara Harpham, Chair of the Medical Technology Group
After the Autumn 2024 budget was announced, MTI reached out to contacts in MedTech for comment on what it would mean for the industry, as well as being inundated with comments from the wider life sciences sector.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, flags the regulations that herald a new Post-Market Surveillance regime for Medical Devices in the UK.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights a new government strategy that feature the potential economic contribution of the life sciences.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation encourages the MedTech sector to engage with the latest Cabinet Office consultation on soon to be implemented procurement guidelines.
Chris Whitehouse, political consultant and expert on MedTech policy reports on a new initiative from the Department for Science, Innovation & Technology that will drive access to new technologies, including AI and bioengineering in the MedTech sector
Openness around quality and outcomes on a scale like never before is needed to understand and solve problems, prevent harm and complexity, focus resources effectively, and restore public confidence in the NHS, writes Dr Mark Ratnarajah.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights a new strand of the Department of Health and Social Care that will help drive developments in the MedTech sector.
Paul Hardman, Managing Consultant for Product Chemistry at vape compliance and regulatory specialist Broughton, explains the route manufacturers can take to develop NGPs as approved medical devices in the UK.
Michael King, Senior Director, Product & Strategy, Technology Solutions at IQVIA talks about the future of quality and regulatory in the MedTech industry.
